Reports

Ideas That Generate Results

Genetic Testing Market Outlook 2020

Genetic Testing Market Outlook 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2015| No. of Pages : 135

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1600.00
Hard Copy Mail Delivery
US$ 1600.00
Electronic Access - Multi-User License
US$ 2500.00

1. Analyst View

2. Research Methodology

3. Genetic Testing Overview
     3.1 Application and Advantages
     3.2 Methods

4. Global Genetic Testing Market Overview
     4.1 Market Outlook
     4.2 Genetic Testing Laboratories - Unmet Need Analysis
     4.3 Direct-to-Consumer (DTC) Genetic Testing

5. Drivers & Challenges
     5.1 Drivers
            5.1.1 Increasing Public Awareness for Genetic Tests
            5.1.2 Rising Incidence of Chronic Diseases
            5.1.3 Growth in Ageing Population
     5.2 Challenges
            5.2.1 Decline in Fertility Rates
            5.2.2 Ethical and Policy Issues

6. Disease-Wise Analysis
     6.1 Alzheimer's Disease
     6.2 Cystic Fibrosis
     6.3 Cancer
     6.4 Bloom Syndrome

7. Country-Level Analysis
     7.1 US
            7.1.1 Market Overview
            7.1.2 Recent Developments
     7.2 Europe
            7.2.1 Market Overview
            7.2.2 Recent Developments
     7.3 Asia-Pacific
            7.3.1 Market Overview
            7.3.2 Recent Developments

8. Emerging Sectors
     8.1 Next-Generation Sequencing (NGS)
     8.2 Non-Invasive Prenatal Testing (NIPT)
     8.3 Whole Genome Sequencing (WGS) for Cancer
     8.4 Personalized Medicine

9. Genetic Testing Regulation

10. Competitive Assessment
     10.1 Abbott Laboratories
            10.1.1 Company Overview
            10.1.2 Product Offering
            10.1.3 Key Financials
            10.1.4 Recent Developments
            10.1.5 Strengths & Weaknesses
     10.2 Roche Diagnostics
            10.2.1 Company Overview
            10.2.2 Product Offering
            10.2.3 Key Financials
            10.2.4 Recent Developments
            10.2.5 Strengths & Weaknesses
     10.3 Myriad Genetics, Inc.
            10.3.1 Company Overview
            10.3.2 Product Offering
            10.3.3 Key Financials
            10.3.4 Recent Developments
            10.3.5 Strengths & Weaknesses
     10.4 Thermo Fisher Scientific
            10.4.1 Company Overview
            10.4.2 Product Offering
            10.4.3 Key Financials
            10.4.4 Recent Developments
            10.4.5 Strengths & Weaknesses
     10.5 Agilent Technologies Inc.
            10.5.1 Company Overview
            10.5.2 Product Offering
            10.5.3 Key Financials
            10.5.4 Recent Development
            10.5.5 Strengths & Weaknesses
     10.6 Hologic, Inc.
            10.6.1 Company Overview
            10.6.2 Product Offering
            10.6.3 Key Financials
            10.6.4 Recent Developments
            10.6.5 Strengths & Weaknesses
     10.7 Illumina, Inc.
            10.7.1 Company Overview
            10.7.2 Product Offering
            10.7.3 Key Financials
            10.7.4 Recent Developments
            10.7.5 Strengths & Weaknesses
     10.8 Qiagen NV
            10.8.1 Company Overview
            10.8.2 Product Offering
            10.8.3 Key Financials
            10.8.4 Recent Developments
            10.8.5 Strengths and Weaknesses
     10.9 Cepheid
            10.9.1 Company Overview
            10.9.2 Product Offering
            10.9.3 Key Financials
            10.9.4 Recent Developments
            10.9.5 Strengths and Weaknesses
     10.10 Affymetrix, Inc.
            10.10.1 Company Overview
            10.10.2 Product Offering
            10.10.3 Key Financials
            10.10.4 Recent Developments
            10.10.5 Strength and Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.